Virax Biolabs (VRAX) Falls 18% on Lack of Leads
We recently published 10 Stocks Losing Big. Virax Biolabs Group Ltd. (NASDAQ:VRAX) is one of the worst performers of Tuesday.
Virax Biolabs Group Ltd (VRAX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,385 | $77,572 | 0% | |
| 2. | 4 | $12 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
10 Biotech Stocks With The Biggest Upside
In this article, we discuss the 10 biotech stocks with the biggest upside. The biotechnology sector has been one of the most profitable growth spaces in the stock market over the past few years.
10 Best Penny Stocks to Buy in September
In this article, we will take a look at the 10 best penny stocks to buy in September.